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0022-2836/$ - see front matter © 2011 EEarlier, we identified mutations in the first transmembrane segment (TMS1)
of UapA, a uric acid-xanthine transporter inAspergillus nidulans, that affect its
turnover and subcellular localization. Here, we use one of these mutations
(H86D) and a novel mutation (I74D) as well as genetic suppressors of them,
to show that TMS1 is a key domain for proper folding, trafficking and
turnover. Kinetic analysis of mutants further revealed that partial misfolding
and deficient trafficking of UapA does not affect its affinity for xanthine
transport, but reduces that of uric acid and confers a degree of promiscuity
towards the binding of other purines. This result strengthens the idea that
subtle interactions among domains not directly involved in substrate binding
refine the selectivity of UapA. Characterization of second-site suppressors of
H86D revealed a genetic interaction of TMS1 with TMS3, the latter segment
shown for the first time to be important for UapA function. Systematic
mutational analysis of polar and conserved residues in TMS3 showed that
Ser154 is crucial for UapA transport activity. Our results are in agreement
with a topological model of UapA built on the recently published structure of
UraA, a bacterial homolog of UapA.© 2011 Elsevier Ltd. All rights reserved.Introduction
The family of nucleobase-ascorbate transporters
(NATs), also called the nucleobase-cation sympor-
ter-2 (NCS2) family†, consists of hundreds ofess:
u, Department of
entro de
miro de Maeztu 9,
base-ascorbate
gment; GFP, green
lsevier Ltd. All rights reservemembers present in nearly all organisms, a promi-
nent exception being Saccharomyces cerevisiae and
several protozoa. At present, the function and
specificity of nearly 20 NAT proteins are known.1–3
These proteins come from bacteria, fungi, plants and
mammals. All non-mammalian homologs of known
function are specific for nucleobases; namely, xan-
thine, uric acid or uracil.1,2 The mammalian NATs
transport either L-ascorbic acid (SVCT1 and SVCT2
proteins in several mammals, including humans4,5
or nucleobases; namely, uracil, xanthine or hypo-
xanthine (in the rat homolog SNBT16). The bacterial,
fungal and plant NATs are high-affinity H+ sym-
porters, whereas the mammalian homologs use Na+
for L-ascorbate or nucleobase symport.1–3,6 All NATs
are predicted to contain 12–14 putative transmem-
brane segments (TMS) and cytoplasmically located
N- and C-tails, but there was no direct structurald.
568 Functional Analysis of TMS1 and TMS3 in UapAdata for anymember of this family until very recently
(see below).
The UapA transporter of the filamentous fungus
Aspergillus nidulans7,8 is the prototype of the NAT
family and one of the most extensively studied
carriers concernedwith regulation of transcription9,10
and endocytosis via ubiquitination,11 butmostlywith
respect to structure–function relationships.1,2,12
Through many rounds of alternating rationale and
random mutational approaches and construction of
chimeric molecules, combined with physiological
tests, detailed analysis of transport kinetics and the
use green fluorescent protein (GFP)-tagged versions
of mutated UapA molecules, we have proposed
models to explain how UapA functions and selects
its substrates, despite the fact that no direct structural
study is available.13–19
In particular, it is known that UapA is a high-
affinity, high-capacity symporter of H+ and xan-
thine or uric acid and that several analogs of these
purines, especially those that do not have modifica-
tions in positions N1-H and N9 or=O8 of the purine
ring, can also act as substrates or ligands of UapA,
albeit with lower affinity. Four fully conserved
amino acid residues (Q85, E356, D388 and N409)
have been found to be irreplaceable for function,
whereas eight more partially conserved residues
(N71, Q113, Q408, G411, T417, R481, T526 and F528)
are crucial for determining the transport kinetics
and substrate specificity of UapA. According to
standard topological algorithms, all functionally
important residues in UapA map in four distinct
regions; TMS1 and its flanking segments, the
amphipathic segment including TMS8-TMS9, the
TMS10-TMS11 cytoplasmic loop and TMS12. Strong
genetic and biochemical evidence has shown that
the amphipathic TMS8-TMS9 region, which in-
cludes most of the functionally important residues,
hosts the basic elements of the substrate-binding
site.16–19 One residue in this region, Q408, has been
shown to be involved in direct contacts with either
N9 or=O8 of xanthine or uric acid, respectively. The
other three functional regions (TMS1, TMS10-
TMS11 cytoplasmic loop and TMS12) appear to
interact dynamically with each other and with the
TMS8-TMS9 substrate-binding domain, acting as
gating elements or selectivity filters that determine
the substrate affinity and specificity of UapA.19
Most of the above conclusions concerning UapA,
especially those concerning the TMS8-TMS9 domain
and TMS12 region, are supported by reverse
genetics and Cys-scanning mutational analysis of
the XanQ xanthine transporter in Escherichia coli,
which is the most extensively studied bacterial
member of the NAT family.20–24
Interestingly, the great majority of functional
mutations of UapA do not affect the folding or
turnover of UapA, as judged by the normal
localization of the relevant mutant forms of GFP-tagged transporter in the plasma membrane. In fact,
the only mutations affecting UapA localization and
turnover are a handful of substitutions of residues in
TMS125 or deletions/insertions of one or two
residues in the loop linking TMS10 with TMS11.26
In this work, we used previously characterized and
novel TMS1 mutations that result in ER-retention
and/or increased turnover of UapA, as well as
genetic suppressors of these mutations, to show that
TMS1 and a TMS1–TMS3 interaction are crucial for
proper folding, trafficking and turnover of UapA.
Subsequently, using a systematic mutational analy-
sis, we show that Ser154 within TMS3 is crucial for
UapA transport activity. Our results are evaluated in
relation to a three-dimensional topological model of
UapA built on the recently published structure of
UraA, a bacterial NAT homolog.Results
TMS1 mutations affect UapA folding, trafficking
and turnover
H86 mutations (H86A, H86D and H86K) isolated
earlier lead to increased turnover of UapA through
sorting and degradation in the vacuoles at 25 °C.25
H86D also leads to partial retention of UapA in the
ER membrane. Mutation I74D constructed here is
just upstream from the putative TMS1 and leads to
non-conditional, complete ER-retention of UapA.
The subcellular localization of GFP-tagged versions
of UapA-I74D, UapA-H86A and UapA-H86D is
shown in Figure 1a. The relevant mutants have
significantly reduced (H86A and H86D) or abol-
ished (I74D) UapA-mediated radiolabeled [3H]
xanthine uptake, which is reflected in the inability
to grow with uric acid (Fig. 1b) or xanthine (not
shown) as sole nitrogen source, given other purine
transporters besides UapA are knocked-out (strain
details are given in Materials and Methods).
Deficient localization or/and increased turnover of
transporters is expected to be associated with
defective folding. A defect in folding was suggested
by the cryosensitive nature of H86 mutations. We
showed directly that this is the case for the UapA-
H86D mutant, where ER retention is indeed
associated with evidence for an unfolded protein
response.27 As expected, the UapA-H86A mutant,
which is not retained in the ER, similar to wild type,
did not show any evidence for an unfolded protein
response (UPR: Fig. 1c). Interestingly, however, in
the case of H86 mutations, where a fraction of UapA
reaches the plasma membrane and thus allows
direct measurements of transport rates and Km
values for xanthine, uric acid or other purines,
folding defects have been shown not to affect the
activity of UapA significantly.25
Fig. 1. Functional characterization of TMS1mutations. (a) Epifluorescent microscopic analysis of GFP-taggedwild type
(wt) and mutant alleles (H86A, H86D and I74D) of UapA. UapA-GFP labels primarily the plasma membrane in wt and
H86D, but distinct cytoplasmically labeled structures appear in all mutants. Arrows in H86D and I74D depict perinuclear
ER rings (membranes). UapA-GFP in H86A labels the plasma membrane but mostly cytoplasmic compact structures,
which correspond to vacuoles. (b) Growth with 0.5 mM uric acid (UA) as sole nitrogen source and UapA-mediated
radiolabeled 3H-xanthine initial uptake rates (%) in control strains (uapA+ and ΔuapA) and TMS1 mutants. Values
represent averages of three independent experiments with standard deviation b20%. (c) Evidence for unfolded protein
response in the mutants expressing UapA-H86D. hsp70 (ANID_02062.1) transcript study-state levels detected by northern
blot analysis of total RNA (10 μg in all lanes). A five-fold increase was estimated in H86D compared to wt or H86A.
569Functional Analysis of TMS1 and TMS3 in UapAGenetic suppression of TMS1 mutations
In order to further understand how missense
mutations in TMS1 affect UapA turnover and
subcellular trafficking, we selected genetic revertants
of mutations H86D and I74D by standard UV
mutagenesis. The relevant mutants expressing
UapA-H86D or UapA-I74D in an appropriate genetic
background cannot grow with uric acid as soleTable 1. Identity and location of I74D and H86D suppressors
Amino acid substitution Topology in UapA
I74D N-terminal/TMS1
A. Suppressors of I74D
I74G N-terminal/TMS1
I74V N-terminal/TMS1
I74A N-terminal/TMS1
I74N N-terminal/TMS1
H86D TMS1
B. First-site suppressors of H86D
H86V TMS1
H86N TMS1
C. Second-site suppressors of H86D
M151I TMS3
M151V TMS3
The nucleobase substitutions of the wild type uapA codon are shown
amino acid residue (Ile74 or His86).nitrogen source at 25 °C (Materials and Methods).
We obtained and characterized several revertants of
both mutants as colonies able to grow with uric acid
as sole nitrogen source. In both cases, all revertants
were found to be due to genetic suppressormutations
located in UapA. The identity and location of these
suppressors is summarized in Table 1. In both cases,
mutagenesis was apparently close to saturation
because several suppressors were obtained twice orNucleotide change Numbers obtained
ATT→ GAT -
GAT→ GGT 2
GAT→ GTT 2
GAT→ GCT 2
GAT→ AAT 1
CAT → GAT -
GAT→ GTT 2
GAT→ AAT 5
ATG→ ATA 1
ATG→ GTG 1
in bold. Suppressors are indicated as substitutions of the original
Fig. 2. (a) Comparative growth tests at 25 °C with 0.5 mM uric acid (UA) as sole nitrogen source and UapA-mediated
radiolabelled 3H-xanthine uptake rates (%) in control strains (uapA+ and ΔuapA), TMS1 mutations and their suppressors
at 37 °C. (b) Comparative growth tests 25 °C with 1 mM xanthine (XAN) as sole nitrogen source at and UapA-mediated
radiolabeled 3H-xanthine initial uptake rates or steady-state uptake levels in the H86D mutation and its suppressor.
Values are averages of three independent experiments with standard deviation b20%.
570 Functional Analysis of TMS1 and TMS3 in UapAmore, or concerned the same codon. All I74D
suppressors corresponded to changes in the originally
mutated codon (first site-suppressors), whereas
H86D revertants were due to both first site-suppres-
sors and mutations replacing Met151 in TMS3 by Val
or Ile (second site-suppressors H86D/M151V and
H86D/M151I). At this point, we constructed isogenic
strains expressing UapA-M151V and UapA-M151I
alleles by themselves; i.e. in the absence of the original
H86D mutation (Materials and Methods).
Functional characterization, expression and
subcellular localization of UapA in suppressors
Figure 2 shows comparative growth tests and
xanthine initial uptake rates of all suppressors,original mutants and control strains. It was apparent
that with respect to Ile74, mutations introducing
hydrophobic amino acids (Ala, Gly and Val) restored
at least 70% of the apparent UapA initial transport
rate,whereas introduction ofAsndid so only partially
(30%). Among H86D suppressors, only the presence
of Asn in the originally mutated codon fully restored
UapA transport rate (∼130%), whereas the presence
of Val in that codon partially re-established the
transport rate of UapA (54%). Surprisingly, second
site-suppressors M151V or M151I did not lead to any
change in xanthine initial uptake rates (28–29%) in
relation to the original mutated strain expressing
H86D (30%). This suggested that substitutions in
M151might have restored, at least to somedegree, the
turnover rather than the function of plasma
Table 2. Substrate specificity profile of mutants and
suppressors
Km/i (μΜ)
Allele Xanthine Uric acid Hypoxanthine
Wt 7 8 n.i.
I74D n.d. n.d. n.d.
I74G 8 35 ∼1000
I74V 28 102 n.i.
I74A 7 195 ∼1000
I74N 5 8 280
H86A 7 23 n.i.
H86D 4 15 n.i.
H86V 19 29 n.i.
H86N 4 28 n.i.
H86D/M151I 4 18 n.i.
H86D/M151V 14 17 n.i.
M151I 25 34 n.i.
M151V 15 107 n.i.
Km/i values were determined as described in Materials and
Methods. n.d., not determined. n.i., no inhibition (90–100%
uptake). The tilde (∼ ) identifies values ≥1000 μM that were
estimated. The results are averages of at least three independent
experiments with three replicates for each concentration and the
standard deviation was b20%.
‡http://www.cbs.dtu.dk/services/TMHMM2,
http://bp.nuap.nagoyau.ac.jp/sosui/, http://www.ch.
embnet.org/software/TMPRED
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tively low transport capacities were exhibited by the
single mutations M151V and M151I (16–22%).
We investigated in more detail the nature of the
suppressors isolated by (i) measuring Km values for
substrates, (ii) establishing an extended substrate
specificity profile through competition assays (Ki
values) and (iii) following the turnover and traffick-
ing of the mutated UapA versions.
Table 2 shows that none of the I74D or H86D
suppressors affect the affinity for xanthine significantly.
For example, even in the case of the maximal (approx.
four-fold) increases in Km, as is the case in I74V or
M151V, this change corresponds to a reduction of less
than 3 kJ/mol in the ΔG0 values governing transport–
substrate interactions.17 Interestingly, however, for
some I74D suppressors, significantly higher affinity
changes were observed specifically for uric acid, the
other physiological substrate of UapA. This is
highlighted in I74V and I74A mutants, which showed
13-fold and 24-fold increases in the Ki values for uric
acid, respectively. We estimated Ki values for
hypoxanthine, a purine not recognized by wild type
UapA. Three Ile74 mutants showed low binding
affinity for hypoxanthine with values of 280 μΜ for
I74N and ∼1 mM for I74A and I74G (Table 2). These
mutants could also recognize adenine, guanine or
uracil with very low (1∼2 mM) affinity (data not
shown). Growth tests showed that none of the Ile74
mutants could grow on purines other than xanthine
or uric acid, which indicates that even in the case of
I74N, I74A and I74G, purines that are non-physio-
logical substrates of UapA are transported very
inefficiently or not at all (not shown).Figure 3a shows a western blot analysis of UapA-
GFP in control strains and mutants H86A, H86D,
H86D/M151I, I74D, I74N and I74G. Quantification of
the steady-state levels of the UapA-GFP protein was
done using the protein levels of the constitutively
expressed actin gene as an internal control. H86A is
the only mutant with a significantly increased
turnover compared to wild type (43% of the wild
type UapA-GFP). UapA-GFP levels were also mod-
erately decreased (69%of thewild type) in suppressor
H86D/M151I.However, the presence of intactUapA-
GFP does not distinguish whether the tagged
transporter is in the plasma membrane or in any
other internalmembrane. Thus, to further analyze the
effect of the different suppressor mutations isolated,
we examined the subcellular localization of UapA-
GFP in the relevant mutant strains. Figure 3b (lower
panel) shows that suppressors of I74D introducing
small hydrophobic residues (Ala, Gly or Val) fully
restored UapA-GFP localization. Introducing a polar
residue at Ile74 (I74N) suppressed the ER-retention
defect observed with I74D, but led to significantly
increased vacuolar sorting of UapA molecules. First-
site suppressors of H86D (H86N andH86V) also fully
restored UapA-GFP localization (not shown). Finally,
the second site-suppressor mutation M151I only
partially restored the localization defect (e.g. ER-
retention) of UapAmolecules carrying H86D (Fig. 3b,
upper right panel). These results were in line with
those from growth tests, western analysis and kinetic
measurements.
Mutational and functional analysis of polar and
conserved residues of TMS3
Second site-suppressors of H86D concerned sub-
stitutions of Met151, a residue in the middle of the
putative TMS3. This segment was predicted, using
various algorithms‡ to form an amphipathic α-helix.
However, a three-dimensional topological model of
UapA (see below) built on the recently published
structure of the UraA (uracil) permease of Escherichia
coli28 shows that TMS3 includes a short β-strand
that includes Met151 (residues 150–153). Six partial-
ly conserved Ser residues (positions 145, 149, 154,
156, 159 and 162) flank the β-strand segment and
should create a polar interface along TMS3 (Fig. 4a).
We substituted all Ser residues of TMS3 with Ala
residues (Materials and Methods) and analyzed the
relevant mutants. We also mutated the only well-
conserved residue of TMS3; Phe155, which is
present in all fungal and bacterial NAT homologs
(Fig. 4a). Growth tests (Fig. 4b) showed that only
two residues were functionally important; S154A
Fig. 3. (a) Western blot analysis of UapA-GFP in control strains and TMS1 mutants and suppressors. Equal amounts of
total protein extracts (50 μg) were loaded in all cases, transferred onto PVDF membranes and hybridized with oligoclonal
anti-GFP and anti-actin antibodies. Relative amounts of UapA-GFP were estimated by normalizing with the wt UapA-
GFP/actin ratio (value set to 10.0) using ImageJ software. (b) Epifluorescent microscopic analysis of GFP-tagged wt and
mutant alleles. Arrows indicate perinuclear ER membranes.
572 Functional Analysis of TMS1 and TMS3 in UapAled to significantly reduced growth at 37 °C and
S162A led to reduced growth at 25 °C, both with uric
acid as the sole nitrogen source. A similar growth
profile was obtained with xanthine as the sole
nitrogen source (data not shown). None of the
TMS3 mutants analyzed could grow with any other
purine as sole nitrogen source (data not shown).
Subcellular localization analysis (Fig. 4d) showed
that none of the TMS3 mutations affected the
localization of UapA-GFP in the plasma membrane.
All mutants showed detectable UapA-mediated
transport (34–127% of wild type values), with
S154A and S162A exhibiting the lowest transport
rates (34% and 45%, respectively) (Fig. 4c).
On the basis of two observations, we studied the
role of Ser154 in UapA function in more detail. First,
Ser154 in UapA corresponds to Asn93 in the E. coli
xanthine permease XanQ. An Asn at this position
has been shown to be crucial for substrate specificity
in bacterial NATs (Discussion).22 Second, Ser154 hasFig. 4. Functional analysis of TMS3 mutants. (a) Μultiple a
Conserved and partially conserved residues are highlighted in
mutations I74D and H86D is indicated. In TMS3, the positio
Secondary structures as predicted by modeling of UapA topol
alignments. Cylinders denote α-helices. A filled flesh denotes a
of TMS3 mutants with 5 mM urea (U) or 0.5 mM uric acid (UA)
UapA-mediated radiolabeled 3H-xanthine uptake rates (%) in
the absence or in the presence of non-radiolabelled substrate
subcellular localization of UapA-GFP in a control strain and Ta crucial position with respect to the putative
substrate-binding site in the UapA structural
model constructed in this study (see below). We
constructed mutation S154N and showed that it did
not affect UapA-GFP localization in the plasma
membrane (Fig. 4d) but had a dramatic effect on the
apparent UapA transport capacity. This is shown by
the lack of growth at 37 °C and at 25 °C with uric
acid as sole nitrogen source (Fig. 4b) and the low
(20%) UapA-mediated transport rate of xanthine
(Fig. 4c) in the corresponding mutant. When the
S154A and S154N alleles were expressed in high-
copy plasmid transformants, partial restoration of
the ability to transport xanthine or uric acid was
established, mostly in the case of S154A. In
principle, restoration of a defect in the apparent
transport capacity of UapA by high-copy expression
implies that the relevant mutations affect either the
intrinsic transport activity and/or the turnover of
the transporter. However, in the case of Ser154lignments of TMS1 and TMS3 of selected NAT sequences.
black and grey boxes, respectively. In TMS1, the position of
ns of all mutants studied here are indicated by arrows.
ogy on the UraA crystal structure are indicated under the
segment-forming β-strand. (b) Comparative growth tests
as sole nitrogen sources at 25 °C or 37 °C. (c) Comparative
control strains (uapA+ and ΔuapA) and TMS3 mutants in
(xanthine 1 mM). (d) Epifluorescence microscopy of the
MS3 mutants.
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Table 3. Substrate specificity profile of S154 mutations
Κm/i (μΜ)
Substrate/ligand UapA+ S154N S154A
Xanthine 8 1.4 7.6
Uric acid 7 10 53
Adenine n.i n.i N1000
Hypoxanthine n.i n.i N1000
Guanine n.i. n.i N1000
Uracil n.i. 523 N1000
2-Thio-xanthine 63 35 48
3-Methyl-xanthine 28 47 62
6-Thio-xanthine 350 326 553
7-Methyl-xanthine n.i. 1000 n.i
8-Methyl-xanthine 100 194 188
9-mEthyl-xanthine 200 634 539
Oxypurinol 100 67 160
Km/i values were determined as described in Materials and
Methods. n.i., no inhibition (90–100% uptake); N1000 indicates
60–75% inhibition at 1mM. The results are averages of at least
three independent experiments with three replicates for each
concentration point and the standard deviation was b20%.
574 Functional Analysis of TMS1 and TMS3 in UapAmutations, the second assumption could be dis-
missed immediately on the basis of the picture from
the epifluorescence microscopic analysis shown in
Fig. 4d. Thus, N154 should affect the bona fide
function of UapA.
To further investigate this idea, we asked whether
substitutions S154A and S154N affected the sub-
strate affinity or the specificity of UapA. Table 3
gives a detailed kinetic analysis of S154A and S154N
mutants, which establishes that both UapA-S154N
and UapA-S154A molecules have substrate affinity
profiles different from that of the wild type UapA. In
both cases, there is minor two- to three-fold
reduction in the affinity for analogs with bulky
substitutions at position 8 or 9 of the purine ring (8-
methylxanthine, 9-methylxanthine, oxypurinol). In
addition, S154A confers an ∼7-fold reduction in the
affinity for uric acid, whereas S154N leads to
moderate increase in the affinity for xanthine and
uracil. Thus, Ser154 is important for determining the
specificity of UapA.
A UapA model based on the UraA structure
Molecular simulations were undertaken in order
to build a UapA model on the basis of its sequence
similarity with the only NAT protein with a known
crystallographic structure; namely, the UraA uracil
permease of E. coli that was published while this
work was in progress.24 The UraA structure was
captured bound with uracil and corresponds to an
inward-facing conformation, occluded from the
periplasmic side of the membrane but open towards
the cytoplasm. The overall topology of the model
UapA shown in Fig. 5 is in very good agreement
with the structure of UraA, which consists of 14
TMSs with N- and C-termini located cytoplasmical-ly (Supplementary Data Table S1). The 14 TMSs are
arranged, as in UraA, in two inverted and inter-
mingled repeats (TMS1-TMS7 and TMS8-TMS14)
related by a rotation of ∼180o. TMS1-TMS4 and
TMS8-TMS11 create a core domain, which hosts a
putative substrate-binding cavity.
In the model UapA structure, TMS1–TMS7 corre-
spond well to the previously proposed TMSs using
different algorithms. The model TMS8 starts 13
amino acid residues downstream from the predicted
TMS8. Significant topological discrepancies between
the model and predicted structures exist immedi-
ately downstream from TMS8. These are concerned
mainly with three short interrupted α-helices in the
model structure (TMS9-TMS10-TMS11), rather than
the predicted single long transmembrane segment
including helices TMS9a and TMS9b.24,26
Consequently, the predicted TMS11-TMS12 corre-
sponds to TMS13-TMS14 in the model structure. It is
noticeable that the segment including the last two
TMS in UapA is longer than that of UraA. The
significance of this observation in relation to the
differential functional role of this segment in bacterial
and fungal NAT members will be discussed else-
where (V. Kosti et al., unpublished results). Notice-
ably, there are two short β-strands in TMS3 and
TMS10 located in the center of the structure, as
observed in UraA. The NAT signature motif lies
immediately downstream from the β-strand segment
of TMS10 and folds as an α-helix. To our satisfaction,
the two essential residues proposed to make direct
contacts with uracil in UraA (E241 in TMS8 and E290
in TMS10) correspond to E356 and Q408, which we
have rigorously shown, by using genetic and bio-
chemical approaches, to be two residues making
direct contact with purines in UapA.16,18,19
With respect to the domains and residues analyzed
in this study, TMS1 and TMS3 are shown to interact
with each other and with TMS10, which includes the
elements necessary (the NAT signature motif) for
substrate binding and transport. The proximity of
TMS1 and TMS3 justifies their genetic and functional
interaction revealed by the second site-suppressors
of H86D. However, His86 is not within bonding
distance to Met151, which lies in the side TMS3 that
does not face TMS1. This result indicates that
suppression of H86D by replacement of Met151
with Ile or Val should occur through an indirect
topological modification. This is supported by the
observation that M151I or M151V also suppress
other H86 mutations (e.g. H86K and H86A), show-
ing the suppression is not allele-specific (data not
shown). By contrast, His86 is within H-bond
distance to Asn409 within the signature motif in
TMS10, a residue absolutely required for UapA
activity. This could very well justify the crucial role
of His86 for UapA function. Mutation I74D, which is
at the N-terminal border of TMS1, might also
somehow affect the crucial interaction of TMS1
Fig. 5. Model structure of UapA built on the crystal structure of UraA (for details, see the text). The overall structure of
UapA as seen from the extracytoplasmic side and from the side are shown in (a) and (b), respectively. Hydrophilic
segments 103–117, 137–147, 169–186 and 243–258, which correspond to amino acid sequence alignment gaps with the
UraA sequence, could not be structured and are not shown. The numbers of TMSs is indicated. Topological relationships
of TMS1, TMS3, TMS8 and TMS10 are shown in more detail in (c) (side view) and (d) (view from the extracytoplasmic
side). For clarity, only the parts of the TMS relevant to the functional mutations analyzed here are shown. Amino acid
residues genetically and functionally analyzed in this work (His86 in TMS1; Met151, Ser154 and Phe155 in TMS3), and
residues involved in substrate binding or transport (Glu356 and Asp360 in TMS8; Gln408 and Asn409 in TMS10) are also
shown (see the text). Notice the two antiparallel β-strands in TMS3 and TMS10 and the close proximity of His86–Asn409
or Ser154–Glu356.
575Functional Analysis of TMS1 and TMS3 in UapAwith TMS3 and/or TMS10. Ser154 in TMS3 is in close
proximity to Glu356 in TMS8, which might also
justify its role in UapA function. Replacement of the
other Ser residues in TMS3 with Ala did not produce
a significant effect on UapA function, and these Ser
residues do not appear to lie in crucial positions in
the model UapA structure.Discussion
We have presented a functional analysis of
rationally designed or genetically selected mutants
affecting UapA function and turnover. The relevantmutations analyzed and discussed here are located
in regions predicted to correspond to TMS1 and
TMS3 in UapA. The concomitant publication of the
first NAT crystal structure from E. coli allowed us to
build a topological model of UapA and to verify the
topology and possible interactions of the mutations
discussed in this work. The model UapA structure
fully justified our results and interpretations con-
cerning the role of specific residues in TMS1 and
TMS3 in UapA folding, turnover and function.
TMS1 appears to be a key domain, as revealed by
the pleiotropic character of mutations mapping
within it. For example, the absolutely conserved
Gln85 residue in the middle of this helix has been
576 Functional Analysis of TMS1 and TMS3 in UapAshown to be essential for transport activity,25
whereas the non-conserved Asn71 and Gln113
residues, located in the flanking cytoplasmic and
extracellular loops of TMS1 have been shown to be
crucial for both UapA specificity and transport
kinetics.19 None of these purely functionally rele-
vant mutations affect UapA turnover or localization
in the plasma membrane. Furthermore, a non-
conserved putative Leu zipper motif (Leu77,
Leu84, Leu91) has been shown to affect both UapA
turnover and transport kinetics, whereas the abso-
lutely conserved His86 and the partially conserved
Ile74 were shown, here and earlier,25 to affect UapA
folding, ER-exit, turnover and specificity. The
central position of TMS1 in the UapA model
structure, which allows it to make contacts with
several other TMS in the core of UapA and,
especially, TMS3, TMS8 and TMS10, justifies the
genetic and biochemical data obtained with TMS1
mutations.
Ile74, which is predicted to map two amino acid
residues upstream from the model TMS1 (Fig. 5b),
could be functionally replaced by Ala, Gly or Val,
which suggest that what is important in that case is
retention of a hydrophobic or a small side chain at
position 74. Most other NAT homologs have either
hydrophobic (Ile, Leu and Met) or Pro residues at
this position (Fig. 4a). This observation suggests that
TMS1 in UapAmight be longer than that of bacterial
homologs and thus include Ile74. In that case,
reducing the hydrophobicity of TMS1 through
substitutions of Ile74 with polar residues (e.g. I74D
and I74N) might affect UapA stability and/ or ER-
exit. The fact that no other similar case has been met
with any hydrophobic to polar replacements in
other TMSs suggests that acquisition of proper
topology of TMS1 constitutes a crucial element for
a functional build-up of UapA. Interestingly, most
mutations concerning Ile74 (I74G, I74A and I74V)
also reduce the affinity of UapA for uric acid and
confer a low but measurable ability to bind other
purines. Earlier data from our laboratory have
shown that a number of UapA mutant versions or
chimeric UapA/UapC molecules have a similarly
reduced affinity for uric acid concomitant with
increased capacity to recognize other purines.18,19,26
On the basis of these observations, we propose that
subtle inter-domain interactions specifically evolved
in UapA, but not in other known NAT homologs,
form the basis for the exceptionally high affinity and
high specificity of UapA for uric acid.19,26 The
results of this study are in accord with this idea
and show that TMS1 is a key domain in inter-
domain interactions.
His86 is one of the few known absolutely
conserved residues in NAT carriers. Given that
members of the NAT family have different specific-
ities and cation selectivity, we propose that His86
should not be involved directly in substrate or cationrecognition.25 This prediction is in accord with our
present results and the model structure. The genetic
analysis showed a functional interaction of His86
(TMS1) with Met151 (TMS3), whereas the model
showed a possible physical interaction of His86
(TMS1) with Asn409 (TMS10). Furthermore, Met151
is in the core of the β-strand of TMS3 which, in the
model structure of UapA, appears to be within
bonding distance to the β-strand of TMS10, just
upstream from the NAT signature motif, in which
Asn409 has been shown to be absolutely essential
for UapA-mediated transport, despite the fact that it
is not necessary for substrate binding.16,19 His86 and
Asn409 substitutions share a similar functional
profile, such as cryosensitivity, loss of transport
capacity and conservation of substrate-binding
ability.16,25 A conserved His (TMS1) – Asn
(TMS10) interaction in NAT carriers might be crucial
for substrate selectivity, as suggested by mutational
analysis of the XanQ permease.22 In this case, it was
shown that specific replacement of the analogous
His in TMS1 (e.g. H31Q) recognizes low-affinity
novel purine bases and analogs. Some other His31
substitutions (H31C and H31L) have led to impaired
XanQ activity whereas others (H31K and H31R)
have impaired expression in the plasma membrane,
similar to the case of H86A and H86D in UapA.
Interestingly, , unlike mutations in His86 in UapA
(or His31 in XanQ), those concerning Asn409 (or
Asn325 in XanQ) do not affect the topology of the
transporter, further suggesting that TMS1 has a
more complex role in NAT folding than that of
TMS10.
On the whole, our results reveal an important
physical and functional interaction of TMS1, TM3
and TMS10 and suggest that mutations in His86
modify the turnover and/or function of UapA
through alteration of this interaction. The impor-
tance of the interactions of TMS1 with other
domains in the NAT family is further supported
by work with the human SVCT1 and SVCT2
transporters, which showed recently that the anal-
ogous His residue in TMS1 (His51) contributes to
substrate binding through a hydrogen bond, where-
as mutations in the adjacent conserved Gln residue
(Gln50) abolish sodium-dependent ascorbate trans-
port activity.29
We showed that Ser154 in TMS3 has a tempera-
ture-dependent effect on the activity of UapA. Single
Ala replacements of all other Ser residues and of the
conserved Phe155, did not produce a significant
functional or turnover effect on UapA. Simultaneous
replacement of all Ser of TMS3, except Ser154, with
Ala residues did not produce a significant defect in
UapA function or turnover (Fig. 4). The suggested
functional role of Ser154 in UapA is further
supported by studies of bacterial NATs permease.22
In XanQ, which is a transporter highly specific for
xanthine, Asn93 corresponds to Ser154 of UapA.
Table 4. Forward primers used for gene specific probes, cloning purposes and for mutant construction
Mutation Oligonucleotide sequence
uapA expBamHI F 5′-CGGGATCCCTCCATCCATCCATTCAACCGAC-3′
uapA XbaI R 5′-GCTCTAGAGCCTGCTTGCTCTGATACTC-3′
hsp70 (ANID_02062.1) F 5′-CGAGGAGCGCCAGGTCA-3′
hsp70 (ANID_02062.1) R 5′-AACTCCTCGGCCTCGGC-3′
I74D 5′-GGCCTCAACGAGAAGGATCCCGTGCTGTTGGCGTTTATC-3′
D86H 5′-GTTTATCCTGGGTCTTCAGCATGCGCTTGCCATGTTGG-3′
S145A 5′-CCAGGTACTATATCGGCGCTGGCGTCCTCTCAGTTATG-3′
S149A 5′-CTATATCGGCAGTGGCGTCCTCGCAGTTATGGGGGTCTCGTTCTC-3′
S154A 5′-GTCCTCTCAGTTATGGGGGTTGCCTTCTCCATCATCTCCGTCGC-3′
S154N 5′-GTCCTCTCAGTTATGGGGGTTAACTTCTCCATCATCTCCGTCGC-3′
F155A 5′-CTCAGTTATGGGGGTCTCGGCCTCCATCATCTCCGTCGCC-3′
S156A 5′-GTTATGGGGGTCTCGTTCGCCATCATCTCCGTCGCCAG-3′
S159A 5′-GTCTCGTTCTCCATCATCGCCGTCGCCAGCGGCGCCTTC-3′
S162A 5′-CTCCATCATCTCCGTCGCCGCCGGCGCCTTCAACCAGATG-3′
S145A on S149A 5′-CCAGGTACTATATCGGCGCTGGCGTCCTCGCAGTTATG-3′
S159A on S156A 5′-GTCTCGTTCGCCATCATCGCCGTCGCCAGCGGCGCCTTC-3′
S162A on S156/159A 5′-CGCCATCATCGCCGTCGCCGCCGGCGCCTTCAACCAGATG-3′
The nucleobase substitutions of the wild type uapA codon are shown in bold. Reverse primers complementary to the forward primers
shown here were used for site-directed mutagenesis.
577Functional Analysis of TMS1 and TMS3 in UapAReplacements N93S and N93A are highly active but
more promiscuous for recognition of analogs at the
imidazole moiety of the substrate, including uric
acid, whereas N93D has low activity. N93T has low
affinity for xanthine or analogs and N93Q or N93C
is inactive.18 It is interesting to note that the N93S
replacement in XanQ partly mimics the specificity of
fungal (UapA) or plant (Lpe1)30 homologs (i.e.
recognition of uric acid), which have Ser at this
position. Furthermore, in UapA, the mirror image
replacement S154N increased xanthine recognition
(fourfold), whereas S154A has reduced (up to
eightfold) uric acid affinity, somehow mimicking
the bacterial XanQ permease (Table 3). A similar
functional role of the analogous residue in the
middle of TMS3 of still another bacterial NAT, the
YgfU uric acid permease, was reported recently (K.
Papakostas and S. Frillingos, personal communica-
tion). Interestingly, Ser154 is close to E356 in TMS8
(Fig. 5c and d), a residue essential for function,19,22
possibly through its direct interaction with sub-
strates (V. Kosti et al., unpublished results).Materials and Methods
Media, strains, growth conditions, and transformation
genetics
Standardmedia were used for growth ofA. nidulans and
E. coli.31 Chemical reagents were obtained from Sigma St.
Louis, MO and from AppliChem GmbH. A strain ΔuapA
ΔuapC ΔazgA argB2 pabaA1 (ΔUapA) carrying a single-
copy plasmid integration of the uapA (UapA+) in the argB
locus served as a standard wild type control. The parental
strain used to select suppressors wasΔuapAΔuapCΔazgA
argB2 pabaA1 (ΔUapA), expressing the uapA–H86D or
uapA–H86D alleles from a single-copy integrated plasmid.pabaA1 is a genetic auxotrophy for p-aminobenzoic acid.
UV mutagenesis is described elsewhere.15 An isogenic
ΔuapA ΔuapC ΔazgA argB2 pabaA1 mutant was the
recipient strain in transformations,32 with uapA alleles
constructed or cloned in vectors pAN510GFP and
pAN510exp or with an ”empty” vector as a negative
control (see below). These vectors allow selection of
transformants based on arginine auxotrophy complemen-
tation. Transformants expressing intact uapA or uapA–gfp
alleles, through either single-copy or multi-copy plasmid
integration events, were identified by PCR and Southern
analysis. In most cases, we selected transformants
originating from single-copy homologous integrations in
the argB locus. Growth tests were performed at 25 °C and
at 37 °C, pH 6.8. The standard purine concentration used
was 0.5 mM in all earlier studies concerning purine
metabolism in A. nidulans.
Plasmid constructions and uapA mutations
pAN510 is a pBluescript vector carrying uapA with its
flanking sequences and the argB gene as a selection
marker.13 pAN510-GFP is a pBluescript vector carrying a
uapA–gfp fusion with its flanking sequences and the argB
gene as a selection marker.33 pAN510exp is a modified
version of pAN510, introducing a BamHI site at the
translation start codon and knocking out a XbaI site in the
pBluescript multicloning region for cloning purposes.19
The uapA orf from the original mutants was amplified by
PCR using primers uapA expBamHI F and uapA XbaI R
(Table 4), cloned in pAN510exp and sequenced (Macrogen
Inc.). Mutations I74D, S145A, S149A, S154A, S154N,
F155A, S156A, S159A and S162A alone and in combina-
tions were constructed by site-directed mutagenesis
according to the instructions accompanying the Quik-
Change® Site-Directed Mutagenesis Kit (Stratagene) on
vector pAN510-GFP, using complementary oligonucleo-
tides carrying the desired substitution (Table 4), and were
confirmed by sequencing. The M151V and M151I muta-
tions were constructed by cloning the H86D/M151V and
H86D/M151I open reading frame from the original
578 Functional Analysis of TMS1 and TMS3 in UapAsecond site H86D suppressors on vector pAN510exp and
reversing the first site mutation using primers D86H
(Table 4). The plasmids constructed were introduced by
transformation into a ΔuapA ΔuapC ΔazgA argB2 pabaA1
strain and the resulting integration events were subjected
to Southern analysis (see below).Standard nucleic acid manipulations
Genomic DNA extraction from A. nidulans was as
described.34 Plasmid preparation from E. coli strains was
done with the Nucleospin Plasmid kit according to the
manufacturer's instructions (Macherey-Nagel GmbH).
DNA bands were purified from agarose gels using the
Nucleospin ExtractII kit according to the manufacturer's
instructions (Macherey-Nagel GmbH). Southern and
northern blot analyses were performed as described.35
Total RNA extraction from A. nidulans was done with the
TRIzol® reagent according to the manufacturer's instruc-
tions (Invitrogen). In northern blots, equal RNA loading
(5∼10 μg) was estimated by measurement of absorbance
at wavelengths of 260 nm and 280 nm and controled by
estimating the amount of rRNA as described.35 [32P]dCTP-
labeled molecules used as hsp70 (ANID_02062.1) or uapA-
specific probes were prepared using a random hexanu-
cleotide primer kit following the supplier's instructions
(Takara Bio Inc.) and purified on MicroSpin™ S-200 HR
columns, following the supplier's instructions (Roche
Applied Science). Labeled [32P]dCTP (3000 Ci/mmol)
was purchased from the Institute of Isotopes Co., Ltd.
Restriction enzymes were from Takara Bio Inc. Conven-
tional PCR reactions were done with KAPATaq DNA
polymerase (KAPABIOSYSTEMS, USA). Cloning and
amplification of products were done with Pfx Platinum
(Invitrogen) or Phusion® Flash High-Fidelity PCR Master
Mix (New England Biolabs).§www.genome.jp/tools/clustalwMembrane protein extraction andwestern blot analysis
Cultures for protein extraction were prepared as
described.33 Mycelia from cultures were harvested, frozen
and broken in liquid nitrogen. All subsequent steps were
done at 4°C. Cell extracts were suspended in extraction
buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 5 mM
EDTA pH 8.0) supplemented with Protease Inhibitor
Cocktail (Sigma) and 0.2 mM phenylmethanesulfonyl
fluoride (PMSF). Unbroken cells and debris were removed
by centrifugation for 3 min at 3000 rpm. The crude extracts
were precipitated with 5% (w/v) TCA and centrifuged for
5 min at 13000 rpm. Pellets were recovered and suspended
in extraction buffer supplemented with Protease Inhibitor
Cocktail and 0.2 mM PMSF. Equal sample loading was
estimated by Bradford assay. Total proteins (50 μg) were
separated by SDS-PAGE (10% (w/v) polyacrylamide gel)
and electroblotted (Mini PROTEAN™ Tetra Cell, BIO-
RAD) onto a PVDF membrane (Macherey-Nagel GmbH)
for immunodetection. The membrane was treated with 2%
(w/v) non-fat dry milk or according to the manufacturer's
instructions and immunodetection was done with a
primary mouse anti-GFP monoclonal antibody (Roche
Applied Science), or a mouse anti-actin monoclonal (C4)
antibody (MP Biomedicals) and a secondary goat anti-
mouse IgG HRP-linked antibody (Cell Signaling). Blotswere developed by the chemiluminescent method using
the West Pico SuperSignal reagent (Pierce) and SuperRX
Fuji medical X-Ray films (FujiFILM Europe GmbH).
Kinetic analysis
[3H]Xanthine uptake in conidiospores was assayed at
37 °C or 25 °C as described.14,17,36 Radiolabeled purines
(19.6–33.4 Ci/mmol) were obtained from Moravek Bio-
chemicals (Brea, CA). Ki values were calculated from the
Cheng and Prusoff equation:
Ki = IC50 = 1 = L= Kmð Þ½ 
where L is the permeant concentration.17
Epifluorescence microscopy
Samples for fluorescence microscopy were prepared as
described.33 In brief, the samples were incubated on
coverslips in liquid Minimal Medium supplemented with
urea as nitrogen source for 12–14 h at 25 °C, observed on
an Axioplan Zeiss phase-contrast epifluorescent micro-
scope with appropriate filters, and the resulting images
were acquired with a Zeiss MRC5 digital camera using
AxioVs40 V4.40.0 software. Images were then processed
with Adobe Photoshop CS2 V9.0.2 software.
Model construction, validation and molecular
simulations
Alignment of UapA and UraA was done with Clus-
talW§ and the best model was built using MODELLER 9.8
software.37 A stepwise validation approach was followed,
consisting of MD model optimization, comparison with
existing experimental data and, finally, visual inspection.
First, theoretical models were subjected to 2.5 ns of
stochastic dynamics simulation and found to berelatively
stable, with a measured RMSD of alpha carbons from
starting coordinates not exceeding 3 Å. After SD optimi-
zation, the best models were tested for structural
consistency by considering all available experimental
data. Both were in good accordance with mutagenesis
and kinetics studies presented earlier and in the present
study.
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